G protein-coupled receptors (GPCRs) are the most abundantly expressed proteins in the human body, regulating diverse ...

Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion to ...

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How is the field adapting to meet these new demands?

According to a new study published in Nature Communications, researchers at the Department of Laboratory Medicine, Karolinska Institutet, have made a significant leap in drug discovery and development ...

Figure 1. This figure depicts the four categories of protein druggability target screening tools discussed in this section, which include structure-based methods, sequence-based methods, machine ...

Mankind Pharma collaborates with Denovo Sciences for AI-driven drug discovery, aiming to enhance candidate quality and reduce ...

A shortcut for drug discovery: Novel method predicts on a large scale how small molecules interact with proteins by CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences ...

Researchers from the University of Cincinnati College of Medicine and Cincinnati Children's Hospital have found a new method to increase both speed and success rates in drug discovery. The study, ...

Researchers developed a novel reagent that enhances the precision of drug synthesis. This innovative method introduces a new sulfur fluoride exchange (SuFEx) reagent that allows for highly controlled ...

AI is becoming more capable, but its value still depends on the data, questions and decisions behind it. Where is it ...

Moffitt Cancer Center researchers have developed a novel reagent that enhances the precision of drug synthesis. This innovative method, published in Nature Communications, introduces a new sulfur ...